These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10029236)

  • 1. Agonist- and antagonist-induced plasticity of rat 5-HT1A receptor in hippocampal cell culture.
    Nishi M; Azmitia EC
    Synapse; 1999 Mar; 31(3):186-95. PubMed ID: 10029236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A; Sebben M; Bockaert J
    Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system.
    Khawaja XZ; Smith DL; Nawoschik SP; Zhang J; Dunlop J; Dilks DW; Olsen M; Schechter LE
    J Neurochem; 2006 Jul; 98(1):134-45. PubMed ID: 16805803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing.
    Martin LP; Jackson DM; Wallsten C; Waszczak BL
    J Pharmacol Exp Ther; 1999 Feb; 288(2):820-6. PubMed ID: 9918594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonist-induced increase in 5-HT1A-receptor expression in adult rat hippocampus and cortex.
    Abbas SY; Nogueira MI; Azmitia EC
    Synapse; 2007 Jul; 61(7):531-9. PubMed ID: 17447257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-hydroxytryptamine 1A receptor activation protects against N-methyl-D-aspartate-induced apoptotic cell death in striatal and mesencephalic cultures.
    Madhavan L; Freed WJ; Anantharam V; Kanthasamy AG
    J Pharmacol Exp Ther; 2003 Mar; 304(3):913-23. PubMed ID: 12604665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT1A receptor activation increases hippocampal acetylcholine efflux and motor activity in the guinea pig: agonist efficacy influences functional activity in vivo.
    Wilkinson LO; Middlemiss DN; Hutson PH
    J Pharmacol Exp Ther; 1994 Aug; 270(2):656-64. PubMed ID: 8071858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors.
    Jordan S; Chen R; Koprivica V; Hamilton R; Whitehead RE; Tottori K; Kikuchi T
    Eur J Pharmacol; 2005 Jul; 517(3):165-73. PubMed ID: 15985260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperammonemia increases serotonin 1A receptor expression in both rat hippocampus and a transfected hippocampal cell line, HN2-5.
    Alexander JJ; Banerjee P; Dawson G; Tonsgard JH
    J Neurosci Res; 1995 May; 41(1):105-10. PubMed ID: 7674372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic evidence for 5-HT1A receptors associated with human retinal pigment epithelial cells in culture.
    Nash MS; Osborne NN
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):510-9. PubMed ID: 9040484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 8-OH-DPAT on hippocampal NADH fluorescence in vivo in anaesthetized rats.
    Rex A; Fink H
    J Neurosci Res; 2006 Mar; 83(4):551-6. PubMed ID: 16435395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
    Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward brain imaging of serotonin 5-HT1A autoreceptor internalization.
    Zimmer L; Riad M; Rbah L; Belkacem-Kahlouli A; Le Bars D; Renaud B; Descarries L
    Neuroimage; 2004 Jul; 22(3):1421-6. PubMed ID: 15219613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo.
    Carrasco GA; Van de Kar LD; Jia C; Xu H; Chen Z; Chadda R; Garcia F; Muma NA; Battaglia G
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1078-86. PubMed ID: 17159160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-Hydroxy-2-(di-n-propylamino)-tetralin inhibits food intake in fasted rats by an action at 5-HT1A receptors.
    Ebenezer IS; Arkle MJ; Tite RM
    Methods Find Exp Clin Pharmacol; 2007 May; 29(4):269-72. PubMed ID: 17609739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat.
    Wang S; Zhang QJ; Liu J; Wu ZH; Wang T; Gui ZH; Chen L; Wang Y
    Neuroscience; 2009 Mar; 159(2):850-61. PubMed ID: 19174182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain.
    Assié MB; Ravailhe V; Faucillon V; Newman-Tancredi A
    J Pharmacol Exp Ther; 2005 Oct; 315(1):265-72. PubMed ID: 15987834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
    Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
    J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.